dimethyl 4-(6-(2-methoxyphenyl)imidazo[2,1-b]thiazol-5-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate

ID: ALA260309

PubChem CID: 24823574

Max Phase: Preclinical

Molecular Formula: C23H23N3O5S

Molecular Weight: 453.52

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1c(-c2ccccc2OC)nc2sccn12

Standard InChI:  InChI=1S/C23H23N3O5S/c1-12-16(21(27)30-4)18(17(13(2)24-12)22(28)31-5)20-19(25-23-26(20)10-11-32-23)14-8-6-7-9-15(14)29-3/h6-11,18,24H,1-5H3

Standard InChI Key:  LKADTWJGOPRQFA-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 32 35  0  0  0  0  0  0  0  0999 V2000
   14.1295   -9.7988    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.3844   -9.0142    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7170   -8.5293    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9932   -5.0919    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9932   -5.9214    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7076   -6.3339    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4267   -5.9214    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4267   -5.0919    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7076   -4.6748    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.1415   -4.6801    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2778   -4.6811    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1406   -6.3349    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1395   -7.1598    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.8555   -5.9234    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.5694   -6.3368    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2788   -6.3339    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5644   -5.9214    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.2788   -7.1588    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.8499   -6.3339    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3045   -9.7988    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0451   -9.0125    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.2171   -9.0162    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9648   -9.8049    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6368  -10.2885    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   15.1682   -8.7591    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7811   -9.3129    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5651   -9.0585    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7373   -8.2508    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1193   -7.6979    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3377   -7.9551    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6087  -10.1196    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.2212  -10.6722    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  4  9  1  0
  5 16  1  0
  5  6  1  0
 16 17  1  0
  6  7  1  0
 16 18  2  0
  7  8  2  0
 17 19  1  0
  6  3  1  0
 20 21  1  0
  8  9  1  0
 20  1  2  0
  8 10  1  0
  4 11  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 20  1  0
  1  2  1  0
  7 12  1  0
 25 26  2  0
  2  3  2  0
 26 27  1  0
 12 13  2  0
 27 28  2  0
  3 21  1  0
 28 29  1  0
 12 14  1  0
 29 30  2  0
 30 25  1  0
  2 25  1  0
  4  5  2  0
 26 31  1  0
 14 15  1  0
 31 32  1  0
M  END

Associated Targets(Human)

CFTR Tclin Cystic fibrosis transmembrane conductance regulator (2075 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CACNA1C Tclin Voltage-gated L-type calcium channel (709 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 453.52Molecular Weight (Monoisotopic): 453.1358AlogP: 3.65#Rotatable Bonds: 5
Polar Surface Area: 91.16Molecular Species: NEUTRALHBA: 9HBD: 1
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 3.15CX LogP: 2.41CX LogD: 2.41
Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.59Np Likeness Score: -1.01

References

1. Budriesi R, Ioan P, Locatelli A, Cosconati S, Leoni A, Ugenti MP, Andreani A, Di Toro R, Bedini A, Spampinato S, Marinelli L, Novellino E, Chiarini A..  (2008)  Imidazo[2,1-b]thiazole system: a scaffold endowing dihydropyridines with selective cardiodepressant activity.,  51  (6): [PMID:18303827] [10.1021/jm070681+]
2. Budriesi R, Ioan P, Leoni A, Pedemonte N, Locatelli A, Micucci M, Chiarini A, Galietta LJ..  (2011)  Cystic fibrosis: a new target for 4-Imidazo[2,1-b]thiazole-1,4-dihydropyridines.,  54  (11): [PMID:21568323] [10.1021/jm200199r]
3. Leoni A, Frosini M, Locatelli A, Micucci M, Carotenuto C, Durante M, Cosconati S, Budriesi R..  (2019)  4-Imidazo[2,1-b]thiazole-1,4-DHPs and neuroprotection: preliminary study in hits searching.,  169  [PMID:30861492] [10.1016/j.ejmech.2019.02.075]

Source